findmyKOL
Clinical trialNCT06282510RecruitingPhase 4Interventional

Nasal Antisepsis for C. Auris Prevention

SponsorMary K HaydenEnrollment120Candida Auris InfectionColonization, Asymptomatic
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a randomized, controlled, open-label trial of effect of 10% povidone iodine intranasal antisepsis on the detection of Candida auris.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Rml Specialty Hospital

    Chicago, Illinois, United States

    Recruiting
  • Rush University Medical Center

    Chicago, Illinois, United States

    Recruiting
  • Rml Specialty Hospital

    Hinsdale, Illinois, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Povidone-iodine →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Jan 2024
Primary completion
31 Dec 2026
Completion
31 Dec 2028
Last update posted
15 Oct 2025
Registered enrollment
120
Registry id
NCT06282510
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.